Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Ribosomal synthesis and de novo discovery of bioactive foldamer peptides containing cyclic β-amino acids


Peptides that contain β-amino acids display stable secondary structures, such as helices and sheets, and are often referred to as foldamers. Cyclic β2,3-amino acids (cβAAs), such as 2-aminocyclohexanecarboxylic acid (2-ACHC), are strong helix/turn inducers due to their restricted conformations. Here we report the ribosomal synthesis of foldamer peptides that contain multiple, up to ten, consecutive cβAAs via genetic code reprogramming. We also report the de novo discovery of macrocyclic cβAA-containing peptides capable of binding to a protein target. As a demonstration, potent binders with low-to-subnanomolar KD values were identified for human factor XIIa (hFXIIa) and interferon-gamma receptor 1, from a library of their 1012 members. One of the anti-hFXIIa macrocyclic peptides that exhibited a high inhibitory activity and serum stability was co-crystallized with hFXIIa. The X-ray structure revealed that it adopts an antiparallel β-sheet structure induced by a (1S,2S)-2-ACHC residue via the formation of two γ-turns. This work demonstrates the potential of this platform to explore the previously inaccessible sequence space of cβAA-containing peptides.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Ribosomal incorporation of 2-ACPCs into model peptides.
Fig. 2: In vitro selection of macrocyclic peptides that contain cβAA against hFXIIa and IFNGR1.
Fig. 3: Inhibition of hFXIIa, mFXIIa and hFXIa.
Fig. 4: Structure of F3 bound to hFXIIa analysed by X-ray crystallography.

Data availability

Coordinates and structure factors have been deposited in the Protein Data Bank, under accession no. 6L63. Other data supporting this study are available in the Supplementary Information.


  1. 1.

    Kudo, F., Miyanaga, A. & Eguchi, T. Biosynthesis of natural products containing β-amino acids. Nat. Prod. Rep. 31, 1056–1073 (2014).

    CAS  PubMed  Google Scholar 

  2. 2.

    Cabrele, C., Martinek, T. A., Reiser, O. & Berlicki, Ł. Peptides containing β-amino acid patterns: challenges and successes in medicinal chemistry. J. Med. Chem. 57, 9718–9739 (2014).

    CAS  PubMed  Google Scholar 

  3. 3.

    Schumann, F., Müller, A., Koksch, M., Müller, G. & Sewald, N. Are β-amino acids γ-turn mimetics? Exploring a new design principle for bioactive cyclopeptides. J. Am. Chem. Soc. 122, 12009–12010 (2000).

    CAS  Google Scholar 

  4. 4.

    Strijowski, U. & Sewald, N. Structural properties of cyclic peptides containing cis- or trans-2-aminocyclohexane carboxylic acid. Org. Biomol. Chem. 2, 1105–1109 (2004).

    CAS  PubMed  Google Scholar 

  5. 5.

    Malešević, M. et al. Spectroscopic detection of pseudo-turns in homodetic cyclic penta- and hexapeptides comprising β-homoproline. Int. J. Pept. Res. Ther. 12, 165–177 (2006).

    Google Scholar 

  6. 6.

    Guthohrlein, E. W., Malesevic, M., Majer, Z. & Sewald, N. Secondary structure inducing potential of β-amino acids: torsion angle clustering facilitates comparison and analysis of the conformation during MD trajectories. Biopolymers 88, 829–839 (2007).

    CAS  PubMed  Google Scholar 

  7. 7.

    Appella, D. H., Christianson, L. A., Karle, I. L., Powell, D. R. & Gellman, S. H. β-peptide foldamers: robust helix formation in a new family of β-amino acid oligomers. J. Am. Chem. Soc. 118, 13071–13072 (1996).

    CAS  Google Scholar 

  8. 8.

    Appella, D. H. et al. Residue-based control of helix shape in β-peptide oligomers. Nature 387, 381–384 (1997).

    CAS  PubMed  Google Scholar 

  9. 9.

    Checco, J. W. et al. α/β-peptide foldamers targeting intracellular protein–protein interactions with activity in living cells. J. Am. Chem. Soc. 137, 11365–11375 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Langer, O., Kahlig, H., Zierler-Gould, K., Bats, J. W. & Mulzer, J. A bicyclic cispentacin derivative as a novel reverse turn inducer in a GnRH mimetic. J. Org. Chem. 67, 6878–6883 (2002).

    CAS  PubMed  Google Scholar 

  11. 11.

    Gopalan, R. D., Del Borgo, M. P., Mechler, A. I., Perlmutter, P. & Aguilar, M. I. Geometrically precise building blocks: the self-assembly of β-peptides. Chem. Biol. 22, 1417–1423 (2015).

    CAS  PubMed  Google Scholar 

  12. 12.

    Kwon, S. et al. Magnetotactic molecular architectures from self-assembly of β-peptide foldamers. Nat. Commun. 6, 8747 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Seoudi, R. S. & Mechler, A. Design principles of peptide based self-assembled nanomaterials. Adv. Exp. Med. Biol. 1030, 51–94 (2017).

    CAS  PubMed  Google Scholar 

  14. 14.

    Müller, M. M. Post-translational modifications of protein backbones: unique functions, mechanisms, and challenges. Biochemistry 57, 177–185 (2017).

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Walsh, C. T., O’Brien, R. V. & Khosla, C. Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds. Angew. Chem. Int. Ed. 52, 7098–7124 (2013).

    CAS  Google Scholar 

  16. 16.

    Dedkova, L. M. et al. β-puromycin selection of modified ribosomes for in vitro incorporation of β-amino acids. Biochemistry 51, 401–415 (2011).

    PubMed  Google Scholar 

  17. 17.

    Maini, R. et al. Incorporation of β-amino acids into dihydrofolate reductase by ribosomes having modifications in the peptidyltransferase center. Bioorg. Med. Chem. 21, 1088–1096 (2013).

    CAS  PubMed  Google Scholar 

  18. 18.

    Maini, R. et al. Protein synthesis with ribosomes selected for the incorporation of β-amino acids. Biochemistry 54, 3694–3706 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Czekster, C. M., Robertson, W. E., Walker, A. S., Soll, D. & Schepartz, A. In vivo biosynthesis of a β-amino acid-containing protein. J. Am. Chem. Soc. 138, 5194–5197 (2016).

    PubMed Central  Google Scholar 

  20. 20.

    Fujino, T., Goto, Y., Suga, H. & Murakami, H. Ribosomal synthesis of peptides with multiple β-amino acids. J. Am. Chem. Soc. 138, 1962–1969 (2016).

    CAS  PubMed  Google Scholar 

  21. 21.

    Iqbal, E. S., Dods, K. K. & Hartman, M. C. T. Ribosomal incorporation of backbone modified amino acids via an editing-deficient aminoacyl-tRNA synthetase. Org. Biomol. Chem. 16, 1073–1078 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Katoh, T. & Suga, H. Ribosomal incorporation of consecutive β-amino acids. J. Am. Chem. Soc. 140, 12159–12167 (2018).

    CAS  PubMed  Google Scholar 

  23. 23.

    Katoh, T., Wohlgemuth, I., Nagano, M., Rodnina, M. V. & Suga, H. Essential structural elements in tRNA(Pro) for EF-P-mediated alleviation of translation stalling. Nat. Commun. 7, 11657 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Dale, T., Sanderson, L. E. & Uhlenbeck, O. C. The affinity of elongation factor Tu for an aminoacyl-tRNA is modulated by the esterified amino acid. Biochemistry 43, 6159–6166 (2004).

    CAS  PubMed  Google Scholar 

  25. 25.

    Dale, T. & Uhlenbeck, O. C. Amino acid specificity in translation. Trends Biochem. Sci. 30, 659–665 (2005).

    CAS  PubMed  Google Scholar 

  26. 26.

    Goto, Y., Katoh, T. & Suga, H. Flexizymes for genetic code reprogramming. Nat. Protocols 6, 779–790 (2011).

    CAS  PubMed  Google Scholar 

  27. 27.

    Katoh, T., Tajima, K. & Suga, H. Consecutive elongation of d-amino acids in translation. Cell Chem. Biol. 24, 1–9 (2017).

    Google Scholar 

  28. 28.

    Katoh, T., Iwane, Y. & Suga, H. Logical engineering of D-arm and T-stem of tRNA that enhances d-amino acid incorporation. Nucleic Acids Res. 45, 12601–12610 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Kwon, S., Jeon, A., Yoo, S. H., Chung, I. S. & Lee, H. S. Unprecedented molecular architectures by the controlled self-assembly of a β-peptide foldamer. Angew. Chem. Int. Ed. 49, 8232–8236 (2010).

    CAS  Google Scholar 

  30. 30.

    Kim, J. et al. Microtubes with rectangular cross-section by self-assembly of a short β-peptide foldamer. J. Am. Chem. Soc. 134, 20573–20576 (2012).

    CAS  PubMed  Google Scholar 

  31. 31.

    Schmitt, M. A., Choi, S. H., Guzei, I. A. & Gellman, S. H. New helical foldamers: heterogeneous backbones with 1:2 and 2:1 α:β-amino acid residue patterns. J. Am. Chem. Soc. 128, 4538–4539 (2006).

    CAS  PubMed  Google Scholar 

  32. 32.

    Yamagishi, Y. et al. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library. Chem. Biol. 18, 1562–1570 (2011).

    CAS  PubMed  Google Scholar 

  33. 33.

    Passioura, T., Katoh, T., Goto, Y. & Suga, H. Selection-based discovery of druglike macrocyclic peptides. Annu. Rev. Biochem. 83, 727–752 (2014).

    CAS  PubMed  Google Scholar 

  34. 34.

    Maas, C. & Renné, T. Coagulation factor XII in thrombosis and inflammation. Blood 131, 1903–1909 (2018).

    CAS  PubMed  Google Scholar 

  35. 35.

    Nickel, K. F., Long, A. T., Fuchs, T. A., Butler, L. M. & Renné, T. Factor XII as a therapeutic target in thromboembolic and inflammatory diseases. Arterioscler. Thromb. Vasc. Biol. 37, 13–20 (2017).

    CAS  PubMed  Google Scholar 

  36. 36.

    Green, D. S., Young, H. A. & Valencia, J. C. Current prospects of type II interferon gamma signaling and autoimmunity. J. Biol. Chem. 292, 13925–13933 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Schroder, K., Hertzog, P. J., Ravasi, T. & Hume, D. A. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163–189 (2004).

    CAS  PubMed  Google Scholar 

  38. 38.

    Mujtaba, M. G. et al. The gamma interferon (IFN-γ) mimetic peptide IFN-γ (95–133) prevents Encephalomyocarditis virus infection both in tissue culture and in mice. Clin. Vaccine Immunol. 13, 944–952 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Hojima, Y., Pierce, J. V. & Pisano, J. J. Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb. Res. 20, 149–162 (1980).

    CAS  PubMed  Google Scholar 

  40. 40.

    Farady, C. J. & Craik, C. S. Mechanisms of macromolecular protease inhibitors. ChemBioChem 11, 2341–2346 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Laskowski, M. & Kato, I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 49, 593–626 (1980).

    CAS  PubMed  Google Scholar 

  42. 42.

    Pathak, M. et al. Coagulation factor XII protease domain crystal structure. J. Thromb. Haemost. 13, 580–591 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Baeriswyl, V. et al. A synthetic factor XIIa inhibitor blocks selectively intrinsic coagulation initiation. ACS Chem. Biol. 10, 1861–1870 (2015).

    CAS  PubMed  Google Scholar 

  44. 44.

    Pathak, M. et al. Crystal structures of the recombinant β-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics. Acta Crystallogr. D 75, 578–591 (2019).

    CAS  Google Scholar 

  45. 45.

    Middendorp, S. J. et al. Peptide macrocycle inhibitor of coagulation factor XII with subnanomolar affinity and high target selectivity. J. Med. Chem. 60, 1151–1158 (2017).

    CAS  PubMed  Google Scholar 

  46. 46.

    Song, H. K. & Suh, S. W. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator. J. Mol. Biol. 275, 347–363 (1998).

    CAS  PubMed  Google Scholar 

  47. 47.

    Perona, J. J., Tsu, C. A., Craik, C. S. & Fletterick, R. J. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI. J. Mol. Biol. 230, 919–933 (1993).

    CAS  PubMed  Google Scholar 

  48. 48.

    Ibrahim, B. S. & Pattabhi, V. Crystal structure of trypsin–turkey egg white inhibitor complex. Biochem. Biophys. Res. Commun. 313, 8–16 (2004).

    CAS  PubMed  Google Scholar 

  49. 49.

    Murakami, H., Ohta, A., Ashigai, H. & Suga, H. A highly flexible tRNA acylation method for non-natural polypeptide synthesis. Nat. Methods 3, 357–359 (2006).

    CAS  PubMed  Google Scholar 

  50. 50.

    Saito, H., Kourouklis, D. & Suga, H. An in vitro evolved precursor tRNA with aminoacylation activity. EMBO J. 20, 1797–1806 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Hirata, K. et al. Achievement of protein micro-crystallography at SPring-8 beamline BL32XU. J. Phys. Conf. Ser. 425, 012002 (2013).

    Google Scholar 

  52. 52.

    Hirata, K. et al. ZOO: an automatic data-collection system for high-throughput structure analysis in protein microcrystallography. Acta Crystallogr. D 75, 138–150 (2019).

    CAS  Google Scholar 

  53. 53.

    Kabsch, W. XDS. Acta Crystallogr. D 66, 125–132 (2010).

    CAS  Google Scholar 

  54. 54.

    Yamashita, K., Hirata, K. & Yamamoto, M. KAMO: towards automated data processing for microcrystals. Acta Crystallogr. D 74, 441–449 (2018).

    CAS  Google Scholar 

  55. 55.

    McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Dementiev, A. et al. Structures of human plasma beta-factor XIIa cocrystallized with potent inhibitors. Blood Adv. 2, 549–558 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  57. 57.

    Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).

    CAS  PubMed  Google Scholar 

  58. 58.

    Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).

    CAS  Google Scholar 

  59. 59.

    Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).

    CAS  PubMed  Google Scholar 

Download references


We thank H. Peacock for proofreading the manuscript. This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (B) (18H02080); Japan Science and Technology Agency (JST) PRESTO of Molecular Technology and Creation of New Functions (JPMJPR14K3); JST CREST Rising Star Award of Molecular Technology to T.K.; JST CREST of Molecular Technologies (JPMJCR12L2) and Japan Agency for Medical Research and Development (AMED), Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) under JP19am0101090 to H.S.

Author information




All authors contributed to writing this work. T.K. carried out the experiments in all sections except for the X-ray crystallography. T.S. and K.H. carried out the X-ray crystallography. K.O. supervised the X-ray crystallography. H.S. directed the programme.

Corresponding authors

Correspondence to Takayuki Katoh or Hiroaki Suga.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Figs. 1–22, Tables 1, 3 and 4, and Results 1 and 2.

Supplementary Tables 2 and 5

Peptide and DNA sequences obtained by the next-generation sequencing and list of RNAs and corresponding primers.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Katoh, T., Sengoku, T., Hirata, K. et al. Ribosomal synthesis and de novo discovery of bioactive foldamer peptides containing cyclic β-amino acids. Nat. Chem. 12, 1081–1088 (2020).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing